Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens

Detalhes bibliográficos
Autor(a) principal: Ackermann, C. L. [UNESP]
Data de Publicação: 2012
Outros Autores: Volpato, R. [UNESP], Destro, F. C. [UNESP], Trevisol, E. [UNESP], Ruas Sousa, N. [UNESP], Guaitolini, C. R. F. [UNESP], Derussi, A. A. P. [UNESP], Rascado, T. S. [UNESP], Lopes, Maria Denise [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.theriogenology.2012.03.030
http://hdl.handle.net/11449/14703
Resumo: The objective was to evaluate ovarian activity reversibility in domestic queens after short-term contraceptive treatment with deslorelin acetate. Ten mature queens were used. In all queens, the estrous cycle was evaluated every 72 h by vaginal cytology (VC) and behavior assessments. When queens had VC characteristic of interestrus or diestrus, one deslorelin acetate implant (4.7 mg) was placed in the subcutaneous tissue of the interscapular region (day of insertion = Day 0). Thereafter, VC was performed every 48 h and on Day 90, implants were removed. At Day 100, estrus and ovulation were induced with 100 IU eCG (im), followed by 100 IU hCG (im), 84 h later (Day 103.5). Queens were ovariohysterectomized on Day 106. Corpora lutea (CL) were counted, oviducts were flushed, and oocytes were identified, isolated and stained to assess viability. In all queens, blood samples for plasma progesterone concentrations were collected once a week, from Days -21 to 106. After deslorelin acetate application, four queens had VC and behavior typical of estrus, and one ovulated. Furthermore, ovulation occurred in three queens that did not have VC or behavior consistent with estrus. After the initial ovarian stimulation, all females had anestrous VC during the deslorelin treatment period. Implants were readily removed. Following implant removal, all females responded to treatments to induce estrus and ovulation. There were (mean +/- SEM) 13.1 +/- 5.5 CL and 8.1 +/- 5.5 oocytes per queen; the oocyte recovery rate was 56.8 +/- 25.4% and all recovered oocytes were viable. We concluded that deslorelin acetate can be used as a reversible short-term contraceptive in domestic cats, because estrus and ovulation were successfully induced following implant removal. (C) 2012 Elsevier B.V. All rights reserved.
id UNSP_69fbda1b3cf572e861ab6a6893fff7f3
oai_identifier_str oai:repositorio.unesp.br:11449/14703
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queensDeslorelin acetateContraceptionDomestic catOocyte recoveryThe objective was to evaluate ovarian activity reversibility in domestic queens after short-term contraceptive treatment with deslorelin acetate. Ten mature queens were used. In all queens, the estrous cycle was evaluated every 72 h by vaginal cytology (VC) and behavior assessments. When queens had VC characteristic of interestrus or diestrus, one deslorelin acetate implant (4.7 mg) was placed in the subcutaneous tissue of the interscapular region (day of insertion = Day 0). Thereafter, VC was performed every 48 h and on Day 90, implants were removed. At Day 100, estrus and ovulation were induced with 100 IU eCG (im), followed by 100 IU hCG (im), 84 h later (Day 103.5). Queens were ovariohysterectomized on Day 106. Corpora lutea (CL) were counted, oviducts were flushed, and oocytes were identified, isolated and stained to assess viability. In all queens, blood samples for plasma progesterone concentrations were collected once a week, from Days -21 to 106. After deslorelin acetate application, four queens had VC and behavior typical of estrus, and one ovulated. Furthermore, ovulation occurred in three queens that did not have VC or behavior consistent with estrus. After the initial ovarian stimulation, all females had anestrous VC during the deslorelin treatment period. Implants were readily removed. Following implant removal, all females responded to treatments to induce estrus and ovulation. There were (mean +/- SEM) 13.1 +/- 5.5 CL and 8.1 +/- 5.5 oocytes per queen; the oocyte recovery rate was 56.8 +/- 25.4% and all recovered oocytes were viable. We concluded that deslorelin acetate can be used as a reversible short-term contraceptive in domestic cats, because estrus and ovulation were successfully induced following implant removal. (C) 2012 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Univ Estadual Paulista FMVZ, Fac Vet Med, Dept Anim Reprod & Vet Radiol, UNESP, Botucatu, SP, BrazilUniv Estadual Paulista FMVZ, Fac Vet Med, Dept Vet Surg & Anesthesiol, UNESP, Botucatu, SP, BrazilUniv Estadual Paulista FMVZ, Fac Vet Med, Dept Anim Reprod & Vet Radiol, UNESP, Botucatu, SP, BrazilUniv Estadual Paulista FMVZ, Fac Vet Med, Dept Vet Surg & Anesthesiol, UNESP, Botucatu, SP, BrazilElsevier B.V.Universidade Estadual Paulista (Unesp)Ackermann, C. L. [UNESP]Volpato, R. [UNESP]Destro, F. C. [UNESP]Trevisol, E. [UNESP]Ruas Sousa, N. [UNESP]Guaitolini, C. R. F. [UNESP]Derussi, A. A. P. [UNESP]Rascado, T. S. [UNESP]Lopes, Maria Denise [UNESP]2013-09-30T18:29:08Z2014-05-20T13:42:18Z2013-09-30T18:29:08Z2014-05-20T13:42:18Z2012-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article817-822application/pdfhttp://dx.doi.org/10.1016/j.theriogenology.2012.03.030Theriogenology. New York: Elsevier B.V., v. 78, n. 4, p. 817-822, 2012.0093-691Xhttp://hdl.handle.net/11449/1470310.1016/j.theriogenology.2012.03.030WOS:000307622200015WOS000307622200015.pdf6666129914663018Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengTheriogenology2.136info:eu-repo/semantics/openAccess2024-09-09T14:01:40Zoai:repositorio.unesp.br:11449/14703Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-09T14:01:40Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
title Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
spellingShingle Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
Ackermann, C. L. [UNESP]
Deslorelin acetate
Contraception
Domestic cat
Oocyte recovery
title_short Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
title_full Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
title_fullStr Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
title_full_unstemmed Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
title_sort Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens
author Ackermann, C. L. [UNESP]
author_facet Ackermann, C. L. [UNESP]
Volpato, R. [UNESP]
Destro, F. C. [UNESP]
Trevisol, E. [UNESP]
Ruas Sousa, N. [UNESP]
Guaitolini, C. R. F. [UNESP]
Derussi, A. A. P. [UNESP]
Rascado, T. S. [UNESP]
Lopes, Maria Denise [UNESP]
author_role author
author2 Volpato, R. [UNESP]
Destro, F. C. [UNESP]
Trevisol, E. [UNESP]
Ruas Sousa, N. [UNESP]
Guaitolini, C. R. F. [UNESP]
Derussi, A. A. P. [UNESP]
Rascado, T. S. [UNESP]
Lopes, Maria Denise [UNESP]
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Ackermann, C. L. [UNESP]
Volpato, R. [UNESP]
Destro, F. C. [UNESP]
Trevisol, E. [UNESP]
Ruas Sousa, N. [UNESP]
Guaitolini, C. R. F. [UNESP]
Derussi, A. A. P. [UNESP]
Rascado, T. S. [UNESP]
Lopes, Maria Denise [UNESP]
dc.subject.por.fl_str_mv Deslorelin acetate
Contraception
Domestic cat
Oocyte recovery
topic Deslorelin acetate
Contraception
Domestic cat
Oocyte recovery
description The objective was to evaluate ovarian activity reversibility in domestic queens after short-term contraceptive treatment with deslorelin acetate. Ten mature queens were used. In all queens, the estrous cycle was evaluated every 72 h by vaginal cytology (VC) and behavior assessments. When queens had VC characteristic of interestrus or diestrus, one deslorelin acetate implant (4.7 mg) was placed in the subcutaneous tissue of the interscapular region (day of insertion = Day 0). Thereafter, VC was performed every 48 h and on Day 90, implants were removed. At Day 100, estrus and ovulation were induced with 100 IU eCG (im), followed by 100 IU hCG (im), 84 h later (Day 103.5). Queens were ovariohysterectomized on Day 106. Corpora lutea (CL) were counted, oviducts were flushed, and oocytes were identified, isolated and stained to assess viability. In all queens, blood samples for plasma progesterone concentrations were collected once a week, from Days -21 to 106. After deslorelin acetate application, four queens had VC and behavior typical of estrus, and one ovulated. Furthermore, ovulation occurred in three queens that did not have VC or behavior consistent with estrus. After the initial ovarian stimulation, all females had anestrous VC during the deslorelin treatment period. Implants were readily removed. Following implant removal, all females responded to treatments to induce estrus and ovulation. There were (mean +/- SEM) 13.1 +/- 5.5 CL and 8.1 +/- 5.5 oocytes per queen; the oocyte recovery rate was 56.8 +/- 25.4% and all recovered oocytes were viable. We concluded that deslorelin acetate can be used as a reversible short-term contraceptive in domestic cats, because estrus and ovulation were successfully induced following implant removal. (C) 2012 Elsevier B.V. All rights reserved.
publishDate 2012
dc.date.none.fl_str_mv 2012-09-01
2013-09-30T18:29:08Z
2013-09-30T18:29:08Z
2014-05-20T13:42:18Z
2014-05-20T13:42:18Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.theriogenology.2012.03.030
Theriogenology. New York: Elsevier B.V., v. 78, n. 4, p. 817-822, 2012.
0093-691X
http://hdl.handle.net/11449/14703
10.1016/j.theriogenology.2012.03.030
WOS:000307622200015
WOS000307622200015.pdf
6666129914663018
url http://dx.doi.org/10.1016/j.theriogenology.2012.03.030
http://hdl.handle.net/11449/14703
identifier_str_mv Theriogenology. New York: Elsevier B.V., v. 78, n. 4, p. 817-822, 2012.
0093-691X
10.1016/j.theriogenology.2012.03.030
WOS:000307622200015
WOS000307622200015.pdf
6666129914663018
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Theriogenology
2.136
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 817-822
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1810021334305996800